Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded Manufacturing Grants By Japanese Government; $165M Has Been Awarded To Date
Portfolio Pulse from Bill Haddad
Arcturus Therapeutics' joint venture mRNA manufacturing partner, ARCALIS, has been awarded manufacturing grants by the Japanese government. To date, $165M has been awarded.
October 04, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Arcturus Therapeutics' partner ARCALIS has been awarded manufacturing grants by the Japanese government. This could potentially boost Arcturus' operations and financials.
The news of ARCALIS, a partner of Arcturus Therapeutics, receiving manufacturing grants from the Japanese government is directly relevant to Arcturus. This could potentially boost their operations and financials as it may lead to increased production and potentially more revenue. Therefore, this news is likely to have a positive impact on Arcturus' stock price in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100